Skip to content
Verana-logo-horizontal-5
  • Clinicians
    • Member Value Tools
      • Practice Insights
      • Verana Trial Connect
      • Quality Measures Dashboards
        • MIPS Advisory Offerings
        • Manual Data Entry
    • Verana Research Network
    • Evolve Registry
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Products
    • Ophthalmology Qdata
      • Anti-VEGF Market Tracker
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
      • Other Ophthalmic Conditions
    • Oncology Qdata
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
    • Clinical Trials
      • Site Explorer
  • Solutions
    • Clinical Research
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
Contact Us
VeranaHealth_Logo
  • Clinicians
    • Member Value Tools
      • Practice Insights
      • Verana Trial Connect
      • Quality Measures Dashboards
        • MIPS Advisory Offerings
        • Manual Data Entry
    • Verana Research Network
    • Evolve Registry
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Products
    • Ophthalmology Qdata
      • Anti-VEGF Market Tracker
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
      • Other Ophthalmic Conditions
    • Oncology Qdata
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
    • Clinical Trials
      • Site Explorer
  • Solutions
    • Clinical Research
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
Contact Us

Published Manuscript

The Tube Versus Trabeculectomy IRIS Registry Study: Cohort selection and follow-up and comparisons to the randomized controlled trial

April 1, 2021
Read More...

Racial, ethnic and insurance-based disparities upon initiation of anti-VEGF therapy for diabetic macular edema in the United States

March 1, 2021
Read More...

Risk of Blindness Among Patients with Diabetes and Newly Diagnosed Diabetic Retinopathy

March 1, 2021
Read More...

Chemical and thermal ocular burns in the United States: An IRIS Registry analysis

March 1, 2021
Read More...

Use of bevacizumab injections in Medicare Fee For Service in the IRIS Registry (Intelligent Research in Sight)

March 1, 2021
Read More...

Tube versus trabeculectomy IRIS Registry one-year composite outcome analysis with comparisons to the randomized controlled trial

February 1, 2021
Read More...

Ophthalmic immune-related adverse events following anti-CTLA-4 or PD-1 therapy recorded in the American Academy of Ophthalmology IRIS Registry

November 1, 2020
Read More...

Factors associated with favorable laser trabeculoplasty response: IRIS Registry Analysis

October 1, 2020
Read More...

Reoperation Rates of Patients Undergoing Primary Noncomplex Retinal Detachment Surgery in a Cohort of the IRIS Registry

August 1, 2020
Read More...

Return to the Operating Room after Vitrectomy for Vitreous Opacities: IRIS Registry Analysis

July 1, 2020
Read More...
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next »
VeranaHealth_Logo

San Francisco | New York | Knoxville

Search

© 2026 Verana Health. All Rights Reserved.

Privacy Policy

Cookie Policy